Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

LRP6 Activators

Common LRP6 Activators include, but are not limited to Lithium Chloride CAS 7447-41-8, GSK-3 Inhibitor IX CAS 667463-62-9, XAV939 CAS 284028-89-3, SB-216763 CAS 280744-09-4 and Lithium Chloride CAS 7447-41-8.

LRP6, or low-density lipoprotein receptor-related protein 6, is an integral membrane protein that plays a pivotal role in the Wnt signaling pathway, a cascade vital for various cellular processes ranging from embryonic development to tissue homeostasis in adults. LRP6, along with its family member LRP5, acts as a co-receptor for Wnt ligands, forming a complex with the Frizzled family of receptors upon ligand binding. The activation of this complex initiates a cascade of intracellular events that ultimately lead to the stabilization of the protein β-catenin. Once stabilized, β-catenin translocates to the nucleus, where it interacts with transcription factors to modulate the expression of Wnt target genes. Given its central role in the Wnt signaling pathway, LRP6 is crucial in determining cellular fate, proliferation, and migration, among other functions.

Activators of LRP6 are molecules or compounds that enhance the activity or expression of LRP6. These activators can function by promoting the interaction of LRP6 with Wnt ligands, by bolstering its expression on the cell surface, or by stabilizing its conformation, ensuring its optimal function as a co-receptor. The presence of LRP6 activators can lead to potentiation of Wnt signaling, influencing the myriad of cellular processes governed by this pathway. A deeper understanding of LRP6 activators offers a window into the intricate dynamics of the Wnt signaling pathway and its implications on cellular decision-making processes. As research continues to unfold the mysteries of cell signaling, the role of LRP6 and its activators emerges as a key piece in the puzzle of cellular communication and regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SKL2001

909089-13-0sc-507410
10 mg
$123.00
(0)

A direct agonist of the Wnt/β-catenin pathway. It acts by binding to the PDZ domain of the LRP6 protein, stabilizing the LRP6/β-catenin/Frizzled complex.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Inhibits GSK3β, which can lead to the stabilization of β-catenin and activation of the Wnt signaling pathway. This might indirectly upregulate LRP6 expression.

GSK-3 Inhibitor IX

667463-62-9sc-202634
sc-202634A
sc-202634B
1 mg
10 mg
50 mg
$58.00
$188.00
$884.00
10
(1)

Inhibitor of GSK3β, thereby activating Wnt/β-catenin signaling, which can indirectly influence LRP6 expression or activity.

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$71.00
$202.00
18
(1)

GSK3β inhibitor that activates Wnt/β-catenin signaling. This can potentially influence LRP6 expression or activity indirectly.